CJC1295 DAC 5/5 mg Peptide (Research Grade)

Long-Acting Growth Hormone Releasing Peptide for Research

CJC1295 DAC 5/5 mg is a long-acting research peptide widely studied for its ability to stimulate sustained growth hormone release. The inclusion of DAC (Drug Affinity Complex) extends the peptide’s half-life, allowing prolonged interaction with growth hormone–releasing hormone (GHRH) receptors in research models. This makes CJC1295 DAC an essential compound for laboratories focused on growth hormone regulation, metabolic balance, muscle recovery, and regenerative research. Supplied as a high-purity lyophilized powder, this product is intended for research use only and not for human consumption.

Benefits & Features

Benefits

• Supports sustained growth hormone release in research settings

• Enables long-acting metabolic and regenerative pathway studies

• Reduces dosing frequency due to extended peptide stability

• Ideal for long-term experimental protocols

Features

• Dual-vial format: 5mg + 5mg

• Research-grade purity (≥99%)

• Lyophilized powder for maximum stability and shelf life

• Manufactured under sterile, quality-controlled conditions

Who It’s Best For

• Growth hormone and metabolic research laboratories

• Scientists studying muscle recovery and tissue regeneration

• Researchers requiring extended-release peptide compounds

• Advanced peptide research institutions

Specifications

• Product Name: CJC1295 DAC

• Strength: 5mg + 5mg

• Form: Lyophilized powder

• Purity: ≥99%

• Use: Research use only

• Storage: Store in a cool, dry place; refrigerate after reconstitution

Performance (Distance, Forgiveness, Feel)

• Distance: Prolonged molecular interaction with GHRH receptors

• Forgiveness: DAC binding enhances stability and reduces degradation

• Feel: Smooth solubility and consistent preparation